Sugi Predict

Sugi Predict / Compounds / SCHEMBL6316639

SCHEMBL6316639

SCHEMBL6316639

CN(C(=O)OC(C)(C)C)[C@H](Cc1cccs1)CN(C)S(C)(=O)=O

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CTSK P43235 2/20 0.41
▸ CTSS P25774 1/20 0.41
▸ CYP2C19 P33261 1/20 0.38
▸ RIPK1 Q13546 1/20 0.37
▸ ALDH1A1 P00352 2/20 0.36
▸ HPGD P15428 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ CTSC P53634 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ L3MBTL1 Q9Y468 2/20 0.35
▸ MMP13 P45452 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.34
▸ BMP1 P13497 5/20 0.33
▸ GBA1 P04062 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ PKM P14618 1/20 0.33
▸ KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6318786 0.83 CTSK (0.45) CTSKCTSSCYP2C19RIPK1CTSC
SCHEMBL6320124 0.83 GHSR (0.47) CTSKCTSSCTSCMMP13BMP1
SCHEMBL6319015 0.81 CTSK (0.45) CTSKCTSSCYP2C19RIPK1CTSC
SCHEMBL8906374 0.79 CTSK (0.52) CTSKCTSSCYP2C19RIPK1ALDH1A1
SCHEMBL1401241 0.76 CYP2C19 (0.50) CTSKCTSSCYP2C19RIPK1ALDH1A1
SCHEMBL3266809 0.76 CTSK (0.43) CTSKCTSSCYP2C19RIPK1SMN1; SMN2
SCHEMBL6317809 0.74 CTSK (0.47) CTSKCTSSCYP2C19RIPK1ALDH1A1
SCHEMBL3266943 0.73 CTSK (0.47) CTSKCTSSCYP2C19RIPK1ALDH1A1
SCHEMBL6121860 0.70 RIPK1 (0.61) RIPK1SMN1; SMN2RAB9AL3MBTL1TDP1
SCHEMBL8906086 0.70 GHSR (0.43) CTSCBMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6939880-B2 Compounds with growth hormone releasing properties NOVO NORDISK A/S (DK) 2005-09-06 — — US disclosed
US-6555570-B2 Growth hormone secretagogous with improved bioavailability NOVO NORDISK A/S (DE) 2003-04-29 — — US disclosed
US-20030055261-A1 Compounds with growth hormone releasing properties HELSINN THERAPEUTICS (U.S.), INC. 2003-03-20 — — US disclosed
US-20030040483-A1 Compounds with growth hormone releasing properties HELSINN THERAPEUTICS (U.S.), INC. 2003-02-27 — — US disclosed
US-6127391-A A PEPTIDE MIMETIC COMPOUND FOR STIMULATING THE RELEASE OF GROWTH HORMONE FROM THE PITUITARY NOVO NORDISK A/S (DK) 2000-10-03 — — US disclosed
US-5977178-A Compounds with growth hormone releasing properties NOVO NORDISK A/S (DK) 1999-11-02 — — US disclosed
EP-0869974-A1 COMPOUNDS WITH GROWTH HORMONE RELEASING PROPERTIES NOVO NORDISK A/S (DK) 1998-10-14 — — EP disclosed
WO-1997023508-A1 COMPOUNDS WITH GROWTH HORMONE RELEASING PROPERTIES NOVO NORDISK A/S (DK) 1997-07-03 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030055261-A1 Compounds with growth hormone releasing properties GHRHR, GHSR, IGFBP1 CTSK 1324/4885CTSS 2319/4885CYP2C19 3634/4885
US-20030040483-A1 Compounds with growth hormone releasing properties GHRHR, GHSR, GRPR CTSK 1778/4885CTSS 2636/4885CYP2C19 3867/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.